Karen K. Ballen

University of Virginia Health System — United States

Medicine · Health Sciences

69h-index18.1kcitations492works9.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(254), Acute Myeloid Leukemia Research(129), Acute Lymphoblastic Leukemia research(72), Polyomavirus and related diseases(66), Chronic Myeloid Leukemia Treatments(54)

Publications491 total

The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroup
Nature Reviews Nephrology·2025· 1 citedOpen Access
Social vulnerability and mortality trends in Acute Myeloid Leukemia in the United States adults (2010 to 2020): The paradoxical role of minority-language communities
Blood·2025Open Access
Mismatching of unrelated donors beyond a single HLA-locus does not adversely impact outcomes at one year following transplantation: Results from the NMDP sponsored ACCESS study
Blood·2025Open Access
Early and sustained palliative care intervention is not superior to on-demand palliative care referral for patients with high-risk leukemias or myelodysplastic syndrome
Blood·2025
Phase II Study of post transplant cyclophosphamide-based graft versus host disease prophylaxis after HLA-mismatched unrelated donor transplantation and reduced intensity conditioning: Results from the NMDP-sponsored access expansion Study
Blood·2025Open Access
Real-world graft utilization after CTN-1101: a registry-based analysis of haploidentical graft versus umbilical cord blood trends
Bone Marrow Transplantation·2025Open Access
Impact of Race and Ethnicity on Outcomes after Umbilical Cord Blood Transplantation
UNC Libraries·2025Open Access
Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries
UNC Libraries·2025Open Access
Correction: Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries
UNC Libraries·2025Open Access
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Journal of Clinical Oncology·2025· 11 citedOpen Access
A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantation
Leukemia Research·2025· 1 cited
A Quality Improvement Project to Coordinate Expensive, Difficult-to-Obtain, Prophylactic Medications before Discharge in an Academic Stem Cell Transplant Unit: 10 Month Results
Transplantation and Cellular Therapy·2025
Evidence into Practice: Changes in Haploidentical Versus Umbilical Cord Blood Graft Utilization for Hematopoietic Cell Transplantation in the U.S. in Relation to a Pivotal Randomized Clinical Trial
Transplantation and Cellular Therapy·2025
Post-Transplant Cyclophosphamide-Based Graft-Versus-host Disease Prophylaxis Following Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation Using Myeloablative Conditioning – Results from the Access Trial
Transplantation and Cellular Therapy·2025· 2 cited
Access to Transplant Care and Social Determinants of Health
Advances in experimental medicine and biology·2025· 1 cited
Trends in volumes and survival after hematopoietic cell transplantation in racial/ethnic minorities
UNC Libraries·2024Open Access
Purpura Fulminans from Capnocytophaga canimorsus in an Immunocompromised Host
Case Reports in Oncology·2024Open Access
Impact of Race and Ethnicity on Outcomes After Umbilical Cord Blood Transplantation
Transplantation and Cellular Therapy·2024· 6 citedOpen Access
Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study
Blood Advances·2024· 12 citedOpen Access
Evidence into practice: Changes in haploidentical versus double umbilical cord blood graft utilization for hematopoietic cell transplantation in the U.S. in relation to a pivotal randomized clinical trial.
Journal of Clinical Oncology·2024· 1 cited
page 1 of 25Next →

Frequent Co-authors

Corey Cutler(14), Robert J. Soiffer(12), Joseph H. Antin(12), Vincent T. Ho(11), Thomas R. Spitzer(11), Bimalangshu R. Dey(10), Eyal C. Attar(10), Yi‐Bin Chen(10), Hillard M. Lazarus(9), Mark R. Litzow(9), Steven L. McAfee(8), Edwin P. Alyea(8), Bipin N. Savani(7), John Koreth(7), Philip C. Amrein(6), Martha Wadleigh(6), Donna Neuberg(6), Richard M. Stone(6), Philippe Armand(6), Jerome Ritz(6)